News & Analysis on Clinical Trial Services & Contract Research And Development
Bidders for DNA-sequencing equipment maker Life Technologies may not have to pay too much more than its current market value of $64 per share, or about $11B, according to an analyst.
Micron Technologies’ new private-equity owner says it plans to grow the particle engineering firm through investment and acquisitions.
Pfizer, Merck, Eli Lilly and a number of other large pharmaceutical companies are calling on the FDA to supplement draft guidance on enrichment strategies for clinical trials with more examples from different therapeutic areas.
The FDA says compounding pharmacies need to be regulated under new legislation following a string of product recalls due to contamination threats.
Formulators still think of excipients first when faced with drug bioavailability difficulties judging by trends that emerged at our online event.
The US FDA has waived normal pre-approval inspection requirements and cleared CMO Cook Pharmica to make an injectable drug that is currently in short supply.
French CMO Indicia production says the acquisition of Biotechnologie Appliquee will strengthen its ready-to-use media manufacturing and add R&D capabilities to its offerings.